[Form 4] AGILENT TECHNOLOGIES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Agilent Technologies (A) president and CEO Michael McMullen reported several equity transactions on November 18, 2025. He sold 911 shares of common stock at $143.24 per share under a pre-arranged Rule 10b5-1 trading plan. On the same date, he received 7,104 shares of common stock issued under Agilent’s Long-Term Performance Program, which carry a 1-year post-vest holding period.

To cover taxes on vesting restricted stock units, he surrendered 3,474 shares back to Agilent at $143.84 per share. He was also granted 33,340 restricted stock units under the 2018 Stock Plan, vesting in four equal annual installments beginning November 18, 2026. After these transactions, he directly beneficially owned 69,028 shares of Agilent common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCDONNELL PADRAIG

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CA 95051

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		S(1)		911	D	$143.24(2)	32,058	D
Common Stock	11/18/2025		A		7,104	A	$0(3)	39,162	D
Common Stock	11/18/2025		F		3,474(4)	D	$143.84	35,688	D
Common Stock	11/18/2025		A		33,340	A	$0(5)	69,028	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 28, 2025.

2. Multiple lots for the same price for this order have been combined.

3. On November 18, 2025, 7,104 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period.

4. The reporting person surrendered 3,474 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3.

5. Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 18, 2026.

	/s/ Bret DiMarco, attorney-in-fact for Mr. McDonnell	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Agilent (A) CEO report on November 18, 2025?

On November 18, 2025, Agilent’s president and CEO reported a sale of 911 shares at $143.24 per share under a Rule 10b5-1 trading plan, receipt of 7,104 shares under the Long-Term Performance Program, a tax-related surrender of 3,474 shares, and a grant of 33,340 restricted stock units.

How many Agilent (A) shares does the CEO beneficially own after these transactions?

Following the reported transactions on November 18, 2025, the president and CEO beneficially owned 69,028 shares of Agilent Technologies, Inc. common stock directly.

What is the vesting schedule for the new Agilent (A) restricted stock units?

The CEO received 33,340 restricted stock units under the Agilent Technologies, Inc. 2018 Stock Plan. These restricted stock units vest in four equal annual installments beginning on November 18, 2026.

What are the terms of the 7,104 Agilent (A) shares issued under the Long-Term Performance Program?

On November 18, 2025, 7,104 shares of Agilent common stock were issued to the CEO under the Long-Term Performance Program. These shares are subject to a 1-year post-vest holding period.

Why did the Agilent (A) CEO surrender 3,474 shares to the company?

The CEO surrendered 3,474 shares of Agilent common stock back to the company to satisfy the tax liability arising from the vesting of restricted stock units, in accordance with Rule 16b-3.

Was the Agilent (A) CEO’s stock sale part of a Rule 10b5-1 plan?

Yes. The 911-share sale on November 18, 2025 was executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 28, 2025.